Your browser doesn't support javascript.
loading
Diagnostic delay and outcome in immunocompetent patients with primary central nervous system lymphoma in Spain: a multicentric study.
Velasco, R; Mercadal, S; Vidal, N; Alañá, M; Barceló, M I; Ibáñez-Juliá, M J; Bobillo, S; Caldú Agud, R; García Molina, E; Martínez, P; Cacabelos, P; Muntañola, A; García-Catalán, G; Sancho, J M; Camro, I; Lado, T; Erro, M E; Gómez-Vicente, L; Salar, A; Caballero, A C; Solé-Rodríguez, M; Gállego Pérez-Larraya, J; Huertas, N; Estela, J; Barón, M; Barbero-Bordallo, N; Encuentra, M; Dlouhy, I; Bruna, J; Graus, F.
Afiliação
  • Velasco R; Neuro-Oncology Unit, Hospital Universitari de Bellvitge-ICO Duran i Reynals, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain. rvelascof@bellvitgehospital.cat.
  • Mercadal S; Department of Cell Biology, Physiology and Immunology, Institute of Neurosciences, Universitat Autònoma de Barcelona, and Centro de Investigación Biomédica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED), Bellaterra, Spain. rvelascof@bellvitgehospital.cat.
  • Vidal N; Department of Neurology, Neuro-Oncology Unit, Hospital Universitari de Bellvitge and ICO L'Hospitalet, C/Feixa Llarga S/N, L'Hospitalet de Llobregat, 08907, Barcelona, Spain. rvelascof@bellvitgehospital.cat.
  • Alañá M; Department of Hematology, Catalan Institute of Oncology-Hospital Duran i Reynals, IDIBELL, Universitat de Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Barceló MI; Neuro-Oncology Unit, Hospital Universitari de Bellvitge-ICO Duran i Reynals, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Ibáñez-Juliá MJ; Department of Pathology, Unit of Neuro-Oncology. Hospital Universitari de Bellvitge-ICO Duran i Reynals, IDIBELL, L'Hospitalet del Llobregat, Barcelona, Spain.
  • Bobillo S; Department of Neurology, Complejo Asistencial Universitario, Salamanca, Spain.
  • Caldú Agud R; Department of Neurology, Hospital Universitario Son Espases, Palma de Mallorca, Spain.
  • García Molina E; Department of Neurology, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
  • Martínez P; Department of Hematology, Vall d'Hebron Institute of Oncology (VHIO), University Hospital Vall d'Hebron, Barcelona, Spain.
  • Cacabelos P; Department of Neurology, Hospital Universitario Miguel Servet, Zaragoza, Spain.
  • Muntañola A; Department of Neurology, Virgen de la Arrixaca University Hospital, Murcia, Spain.
  • García-Catalán G; Department of Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Sancho JM; Department of Neurology, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, La Coruña, Spain.
  • Camro I; Department of Hematology, Hospital Universitario Mutua de Terrassa, Terrassa, Spain.
  • Lado T; Department of Neurosurgery, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
  • Erro ME; Department of Hematology, ICO-IJC-Hospital Germans Trias i Pujol, Badalona, Spain.
  • Gómez-Vicente L; Department of Neurology, Hospital Universitario Cruces, Barakaldo, Vizcaya, Spain.
  • Salar A; Department of Hematology, Hospital Clínico Universitario de Valladolid, Valladolid, Spain.
  • Caballero AC; Neurology Department, Complejo Hospitalario de Navarra, Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.
  • Solé-Rodríguez M; Department of Neurology, Hospital Universitario Quirónsalud Madrid, Pozuelo de Alarcón, Madrid, Spain.
  • Gállego Pérez-Larraya J; Department of Hematology, Hospital del Mar, Barcelona, Spain.
  • Huertas N; Department of Hematology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Estela J; Department of Hematology, Hospital Universitario Virgen del Rocío, Sevilla, Spain.
  • Barón M; Departament of Neurology, Clínica Universidad de Navarra, IdiSNA, Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain.
  • Barbero-Bordallo N; Department of Neurology, Hospital Universitario Severo Ochoa, Leganés, Madrid, Spain.
  • Encuentra M; Department of Neurology, Hospital Parc Taulí, Sabadell, Spain.
  • Dlouhy I; Unit of Neurology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.
  • Bruna J; Department of Neurology, Hospital Universitario Rey Juan Carlos, HURJC-HUIE-HCV, Madrid, Spain.
  • Graus F; Department of Hematology, Catalan Institute of Oncology-Hospital Duran i Reynals, IDIBELL, Universitat de Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain.
J Neurooncol ; 148(3): 545-554, 2020 Jul.
Article em En | MEDLINE | ID: mdl-32524392
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma não Hodgkin / Protocolos de Quimioterapia Combinada Antineoplásica / Irradiação Craniana / Neoplasias do Sistema Nervoso Central / Diagnóstico Tardio / Quimiorradioterapia / Imunocompetência Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Neurooncol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma não Hodgkin / Protocolos de Quimioterapia Combinada Antineoplásica / Irradiação Craniana / Neoplasias do Sistema Nervoso Central / Diagnóstico Tardio / Quimiorradioterapia / Imunocompetência Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Neurooncol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Espanha